logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xin Huang

fudan university
H指数:20
被引数:1,306

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional 3+7 intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a prospective, multicenter, randomized, open-label clinical trial

比较ABC-14方案（azacitidine、venetoclax和chidamide）与传统3+7强化诱导方案或AB-14方案（venetoclax联合azacitidine）在初诊AML中的疗效和安全性：一项前瞻性、多中心、随机、开放标签临床研究的方案

TRIALS
IF2
2025-12-100
PRE
Yan, Honghong; Huang, Xin; Wu, Ping; Deng, Chengxin; Li, Minming; Lai, Peilong; Du, Xin; Weng, Jianyu
Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group

阿扎胞苷、维奈克拉联合氯米芬（ABC-14方案）作为新诊断AML的诱导治疗：一项由ABC-14协作组进行的真实世界回顾性分析

BLOOD
IF23.1
2024-11-050
PRE
Weng, Jianyu; Deng, Chengxin; Huang, Zhenqian; Zhang, Yuming; Ying, Wang; Li, Minming; Wu, Ping; He, Honghua; Ye, Xu; Jiang, Yirong; Dong, Min; Liu, Zhenfang; Li, Xiaoliang; Zheng, Runhui; Zou, Maoquan; Lin, Lie; Zhao, Ying; Zhang, Xiangzhong; Cheng, Shuqin; Guo, Ziwen; Jiang, Xuejie; Li, Zhilun; Tan, Jiaqi; Luo, Chengwei Luo; Wu, Suijing; Lai, Peilong; Li, Yangqiu; Huang, Xin; Du, Xin

研究方向

暂未获取到该数据
Q
Qing Chang
H 指数:21论文数:117被引数:2,050
Q
Qing Chang
H 指数:27论文数:121被引数:3,233
L
Lu Ruan
H 指数:18论文数:69被引数:1,264
蒋
蒋晨
H 指数:37论文数:142被引数:5,785
G
Gezhi Xu
H 指数:26论文数:176被引数:2,420
Y
Yuqiao Ju
H 指数:3论文数:26被引数:29
F
Fengjuan Gao
H 指数:18论文数:79被引数:1,019
Y
Yanqiong Zhang
H 指数:47论文数:303被引数:7,648
Y
Yingqin Ni
H 指数:16论文数:42被引数:1,122
Y
Yuan Zong
H 指数:19论文数:141被引数:1,161